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Background: Provision of in-centre nocturnal hemodialysis (ICNHD; 6–8 hours thrice weekly) is associated with
health benefits, but the economic implications of providing this treatment are unclear.
Objective: We conducted a health care costing study comparing ICNHD to in-centre thrice-weekly conventional
hemodialysis (CvHD).
Design: Micro-costing of both ICNHD and CvHD as practiced at our centre.
Setting: Hemodialysis unit at a tertiary-care hospital in Edmonton.
Participants: An informal survey of 2 other Canadian ICNHD programs was conducted to inform practices that may
deviate from ours to guide sensitivity analysis.
Measurements: Resources consumed for each strategy were determined, and the cost of each unit (CAN $2012)
was used to calculate incremental costs of ICNHD and CvHD.
Methods: We focused on resources that differ between strategies (staffing, dialysis materials, and utilities). The
reference case considered 1:3 staff to patient ratio; alternate scenarios explored nursing pay grade and ratio, full
care vs. self-care dialysis (including training costs), and medication costs.
Results: In the reference case, ICNHD was $61 more costly per dialysis treatment compared with CvHD ($9,538 per
patient per year). Incremental annual costs for staffing, dialysis materials, and utilities were $8,201, $1,193,
and $144, respectively. If ICNHD reduces medication use (anti-hypertensives, bone mineral metabolism medications),
the incremental cost of ICNHD decreases to $8,620 per patient per year. In a scenario of self-care ICNHD utilizing a
staff-to-patient ratio of 1:10, ICNHD is more costly in year 1 ($15,196), but results in cost savings of $2,625 in
subsequent years compared with CvHD.
Limitations: The findings of this cost analysis may not be generalizable to other health care systems, including
other parts of Canada.
Conclusions: Compared to CvHD, provision of ICNHD is more expensive, largely driven by increased staffing costs as
patients dialyze longer. Alternate staffing models, including self-care ICNHD with minimal staff, may lead to net
cost savings. The incremental cost of treatment should be considered in the context of impact on patient health
outcomes, staffing model, and pragmatic factors, such as current capacity for daytime CvHD and the capital costs
of new dialysis stations.
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Contexte: L’hémodialyse nocturne en centre (ICNHD; 6 à 8 heures, trihebdomadaire) est associée à des bienfaits
pour la santé, mais nous connaissons mal les répercussions économiques de l’administration de ce traitement.
Objectifs: Nous avons effectué une étude des coûts de revient des soins de santé en comparant l’ICNHD à
l’hémodialyse conventionnelle en centre sur une base trihebdomadaire (CvHD).
Type d’étude: Le calcul des coûts individuels de l’ICNHD et du CvHD tel qu’effectué dans notre centre.
Contexte/Échantillon: Le service d’hémodialyse d’un hôpital de soins tertiaires d’Edmonton.
Participants: On a effectué un sondage informel dans le cadre de deux programmes canadiens d’ICNHD afin
d’indiquer les pratiques qui pourraient dévier des nôtres, permettant ainsi l’analyse de sensibilité.
Mesures: Les ressources utilisées pour chacune des stratégies étaient déterminées, et le coût de chaque dialyseur
(2 012 $CA) a été pris en compte dans le calcul du coût marginal de l’ICNHD et du CvHD.
Méthodes: Nous nous sommes concentrés sur les ressources qui diffèrent selon la stratégie (dotation en personnel,
matériel d’hémodialyse et équipements). L’hypothèse supposait un ratio personnel-patients de 1 :3; des scénarios
alternatifs examinaient l’échelon de rémunération du personnel infirmier ainsi que les ratios, la prise en charge
totale par rapport à l’auto-dialyse (incluant les coûts de formation), et le coût des médicaments.
Résultats: Dans le scénario de référence, l’ICNHD s’est révélé 61 % plus coûteux par traitement de dialyse que le
CvHD (9 538 $ par patient par an). Les coûts marginaux de dotation en personnel, du matériel de dialyse et des
équipements étaient respectivement de 8 201 $, de 1 193 $ et de 144 $. Si l’ICNHD permet de diminuer l’utilisation
de médicaments (antihypertenseurs, médicaments pour le métabolisme minéral osseux), le coût marginal de l’ICNHD
diminue à 8 620 $ par patient par an. Dans le cas d’ICNHD en auto-dialyse, qui requiert un ratio personnel-patients de
1 :10, l’ICHND est plus coûteux la première année (15 196 $), mais les économies durant les années subséquentes le
rendent comparables au CvHD.
Limites de l’étude: Les conclusions de cette analyse de coûts peuvent se révéler peu valides pour d’autres systèmes
de soins de santé, dont ceux d’autres régions du Canada.
Conclusions: Comparativement au CvHD, la fourniture d’ICNHD est plus coûteuse, principalement en raison du
personnel supplémentaire requis par des séances de dialyse prolongées. Des modèles de dotation alternatifs, incluant
l’ICHND en auto-dialyse qui requiert un minimum de personnel, peut permettre des économies nettes. Le coût
marginal du traitement devrait être considéré, en contexte, selon les répercussions possibles sur l’état de santé final
des patients, les modèles de dotation, et des facteurs pragmatiques tels que la capacité actuelle du CvHD de jour
et les coûts d’investissement de nouvelles stations de dialyse.What was known before and what this adds
Provision of in-centre nocturnal hemodialysis (ICNHD;
6–8 hours thrice weekly) is associated with health ben-
efits, but the economic implications of providing this
treatment are unclear. Using data from a renal program
in Edmonton, Canada, this study examines the incremen-
tal costs of ICNHD compared with conventional HD from
a health care payer perspective.
Background
The cost of caring for patients with end-stage renal disease
(ESRD) is considerable, largely driven by the provision
of chronic dialysis [1]. The majority of ESRD patients
are either not suitable for a kidney transplant, or must
wait an increasing number of years on dialysis until
renal transplantation given the scarcity of available organs.
While strategies to increase peritoneal dialysis have been
implemented in many jurisdictions, hemodialysis (HD)
remains the most common modality, with the majority ofthose (~80%) receiving conventional thrice-weekly inter-
mittent HD in a satellite or in-centre dialysis unit [2].
There is interest in offering nocturnal HD to patients
due to its purported benefits of improved fluid volume
and blood pressure control, regression of left ventricular
hypertrophy, improved phosphate control, and increased
quality of life [3-7]. However, some patients are thought to
be unsuitable candidates for a variety of reasons, including
inappropriate home environment, lack of social support,
inadequate personal resources, or comorbidity precluding
self-administration of HD (e.g. severe visual impairment,
debilitating arthritis, stroke, etc.). In one centre, ~16% of
HD patients were deemed to be appropriate candidates
for home nocturnal HD (HNHD) [8]. As such, renal pro-
grams are considering in-centre nocturnal HD (ICNHD),
typically conducted overnight in an existing in-centre
dialysis unit for 6–8 hours thrice weekly. In addition to
potential improvements in patient health outcomes and
to facilitate patient lifestyle preferences, dialysis providers
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centre patient treatment capacity without further ex-
pansion of existing HD stations.
Several economic analyses have demonstrated that
home HD is either cost neutral or affords cost savings
compared to in-centre conventional HD (CvHD), pre-
dominantly due to savings associated with nursing care
[9-11]; no study has examined ICNHD. To inform rational
use of ICNHD, we sought to determine the incremental




The Northern Alberta Renal Program (NARP) oversees
and manages renal care in the northern Alberta, Canada
with a catchment of approximately 1.7 million. In a pilot
program, 12 patients receive ICNHD (6 per HD shift on
alternate nights) in an outpatient HD unit at a tertiary-care
hospital in Edmonton. This HD unit provides 3 daytime
CvHD shifts (18 HD stations per shift, 4 hours per session)
with staff-to-patient ratio of 1:3. ICNHD occurs from 2200
to 0600 and the 6 patients are cared for by 2 Registered
Nurses (RNs) or 1 RN and 1 Licensed Practical Nurse
(LPN). The patients dialyze in beds to facilitate sleep
(chairs are removed), and space between stations is
increased to allow room for the bed and reduce noise;
dividers are also set up to enhance patient privacy. Pa-
tients are referred for ICNHD at the discretion of their
attending nephrologist, and priority is given to pa-
tients with suboptimal ultrafiltration or clearance on
CvHD, intra-dialytic hypotension, or lifestyle consider-
ations, including employment or education that conflict
with daytime in-centre CvHD; and these patients can-
not perform home HD. The duration of ICNHD ses-
sions ranges from 6 to 8 hours, depending on patient
preference.
Methods
Micro-costing methods, comprised of identification,
measurement, and valuation of resources, was conducted
for ICNHD and CvHD [12]. Identification of relevant
health care resources was conducted through iterative
discussion with ICNHD nursing staff, NARP financial
analyst, clinical engineering, and technical manager
overseeing water treatment, focusing on resource use
that differs between the two modalities. Identified health
care resource categories include staffing, dialysis materials,
and utilities (Additional file 1: Table S1). In the reference
case, HD machine maintenance, patient-borne costs, and
physician billing were equivalent. An informal survey of 2
other Canadian ICNHD programs was conducted to in-
form practices that may deviate from ours to guide sensi-
tivity analysis.Staffing costs accounted for salaries and benefits of
RNs and LPNs. All other staffing costs, including the
salaries of nephrologists, unit clerks, social workers,
and other allied health professionals, were assumed
equivalent between the two HD modalities. HD mate-
rials cost accounted for costs related to dialysis tubing,
dialysis needle, dialyzer, dialysate, and bicarbonate solu-
tion. To reflect our ICNHD setup, we did not include the
cost of setting up and dismantling the HD unit for the
nocturnal shift. Depending on the HD unit, additional
costs relating to minor renovations may need to be
accounted for. Utility costs per treatment factored into
costs relating to water and electricity consumption
(Additional file 1: Table S1).
Staff (RNs and LPNs) cost per dialysis treatment were
calculated on a per hour basis and distributed equally
among the patients based on the staff-to-patient ratio
for the respective dialysis modality. For materials cost,
we tabulated the number of units of the various dialysis
supplies consumed per HD session. As accurate water
and electricity usage per machine per dialysis treatment
for home CvHD and HNHD patients were available, this
data was used to inform utility cost. Respective units of
measurement for water and electricity consumption per
HD session were captured in liters and kilowatt-hours.
The constituent costs were summed to arrive at total
cost per HD session for both ICNHD and CvHD, and
subsequently, calculated on a per patient-year basis. All
costs were expressed in 2012 Canadian dollars.
Scenario analyses were also conducted to reflect other
practices in Canada. A scenario of self-care ICNHD (with
both a 1:6 and a 1:10 staff-to-patient ratio) was assessed,
where patients receive training during the initiation of
ICNHD and then perform machine setup and takedown,
as well as access cannulation, with either no or reduced
nursing assistance. Training costs (inflated to CAN $2012),
arising from 3.65 weeks of training, were obtained from a
micro-costing study of patients enrolled a randomized-
controlled trial (RCT) that compared HNHD and CvHD
[11]. The additional cost of patient training, $17,821 per
patient, which accounts for nursing time, capital costs,
and equipment per patient, is added to the cost of pro-
viding ICNHD in the first year. A scenario exploring the
effect of nursing grade mix (50% RNs vs. 100% RN) on
incremental costs was also explored.
Difference in medication costs for ICNHD patients
versus CvHD patients was examined. We used results
from the Alberta RCT [11] (which used units of medi-
cations and formulary prices inflated to CAN $2012)
to inform medication costs of anti-hypertensive agents,
bone mineral metabolism medications, and erythropoietin-
stimulating agents (ESAs) for those on CvHD. Medication
costs for ICNHD patients were informed by the Alberta
RCT (which showed cost reduction in anti-hypertensive
Wong et al. Canadian Journal of Kidney Health and Disease 2014, 1:14 Page 4 of 7
http://www.cjkhd.org/content/1/1/14agents and bone mineral metabolism medications only)
and other observational studies reporting on medication
use in ICNHD vs. CvHD, which showed cost reduction in
all 3 medication classes [13-18].
ICNHD may be considered as an alternate strategy to
creating new dialysis units and attendant capital costs
when existing patients cannot be accommodated. A
scenario analysis was performed to explore possible in-
cremental costs. We assumed a scenario in which there
is a surplus of HD patients in the context of an existing
HD unit functioning at full capacity. All patients would
then either be accommodated by ICNHD, or be treated
with CvHD in a newly built in-centre dialysis unit. We
explored the effects of size (4, 6, 9 stations) and capacity
(25%, 50%, 75%, 100%) of the new HD unit. Capital costs
of establishing new HD units were based on estimates
from NARP.
Results
In the reference case (1:3 staff-to-patient ratio with nursing
grade of 50% RN), ICNHD was $61 more costly per dialysis
treatment compared with CvHD (Table 1, Additional file 2:
Table S2). Difference in staffing cost was responsible
for greater than 85% of the incremental cost; materials
and utility during ICNHD accounted for 13% and 2%
respectively. Incremental annual costs per dialysis pa-
tient for staffing, dialysis materials, and utilities were
$8,201, $1,193, and $144, respectively for ICNHD vs.
CvHD. Overall, ICNHD was $9,538 more per patient-year
(Table 1).
Accounting for plausible reduction in anti-hypertensive
agents and bone mineral metabolism medications for
ICNHD patients compared to CvHD patients, the cost dif-
ferential between the two HD modalities is reduced from
$9,538 to $8,620 per annum (Table 2). If we also account
for reduction in ESA requirement (suggested in observa-
tional studies, but not shown in RCTs), the cost differen-
tial further reduces to $6,119 per annum.
Scenario analyses of alternate staff-to-patient ratio and
nursing grade of 50% RN are presented in Figure 1. Incre-
mental costs are similar with 100% RN (figure not shown).
A self-care ICNHD program with a 1:10 staff-to-patient
ratio and a nursing grade of 50% RN resulted in an annual
incremental cost of $15,196 (vs. $9,538 in the referenceTable 1 Absolute and incremental costs of ICNHD and CvHD
Cost categories Absolute ICNHD cost ($)
1. Materials per treatment 43.49
2. Staff per treatment 111.38
3. Utilities per treatment 2.73
Total cost per treatment per patient 157.60
Total annual cost per patient 24,585.86
ICNHD: in-centre nocturnal hemodialysis; CvHD: conventional hemodialysis.case) in the patient’s first year of dialysis and annual saving
of $2,625 in subsequent years (Figure 1).
Incremental costs of constructing a new HD unit vs.
providing ICNHD is shown in Table 3. A new HD unit
would be required to operate for close to 10 years at
near-full capacity before the initial capital costs equilibrate
with the increased operating costs of ICNHD (relative
to CvHD). This was consistent across various sizes and
capacities of the new HD unit.
Discussion
In this cost analysis of ICNHD, we have demonstrated
that provision of ICNHD cost approximately $9500 more
per annum per patient relative to CvHD. This is primarily
attributed to increased staffing costs of RNs and LPNs
from both longer duration of dialysis and increased wage
rates for overnight shifts. An alternate scenario of self-
care ICNHD that utilized a higher nursing staff-to-patient
ratio substantially reduce the incremental cost, with some
scenarios demonstrating cost savings after the first year
with ICNHD.
Self-care ICNHD program with a higher nursing staff-
to-patient ratio (1:6 and 1:10) offers an attractive alter-
native from a health payer perspective. This variation of
ICNHD is already operational in other centres (Michael
Copland, personal communication, March 28, 2013). Pa-
tients are trained the same way as for HNHD patients;
they are expected to be competent with all aspects of HD
care, except for machine maintenance. While ICNHD,
compared to CvHD, can potentially lead to net cost sav-
ings, a concern exists in that it may detract from patients
choosing HNHD, for which operating costs are likely
lower and there is stronger evidence of clinical benefits
[4,5]. Accordingly, providers should be encouraged to first
consider HNHD and offer patients the opportunity to
transfer to HNHD after they have completed their training
for self-care ICNHD.
A pragmatic rationale for ICNHD is patient numbers
exceeding existing in-centre HD unit capacity. While
increasing the number of patients on home dialysis
therapies may offset this to some degree, the majority
of dialysis patients are likely to require in-centre HD.
If the capacity of existing in-centre HD units were






Table 2 Impact of difference in medication requirement on relative costs between ICNHD and CvHD
Resource category CvHD1 ($) ICNHD ($) Δ Cost ($, ICNHD – CvHD)
Medication
Anti-hypertensives 756.00 378.00 (−378.00)
ESAs 6,252.00 3751.20 (−2,500.80)
Bone mineral metabolism medications 1,080.00 540.00 (−540.00)
Reference – no difference in medication use (annual cost/patient) 15,048.28 24,585.86 + 9,537.58
Reduced anti-HTN and bone mineral metabolism medications
only (annual cost/patient) 16,884.28 25,503.86 + 8,619.58
Reduced in all medication categories (annual cost/patient) 23,136.28 29,255.06 +6,118.78
1annual cost of CvHD was informed from the Alberta randomized-controlled trial [11].
Assumptions:
- 50% reduction in number of anti-hypertensives required based on observational studies [13-17].
- 40% reduction in required ESA dose based on observational studies [16-18].
-50% reduction in amount of bone mineral metabolism medications required based on observational studies [13,15,16,18].
ICNHD: in-centre nocturnal hemodialysis (7 hour sessions, 3x /week, 1:3 staff-to patient ratio); CvHD conventional hemodialysis (4 hour sessions, 3x /week, 1:3
staff-to-patient ratio); ESAs: erythropoiesis-stimulating agents.
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study showed that the cost of renovating existing space
for a six-station satellite unit is approximately $250,000 to
$300,000 Canadian [19], while the cost of constructing a
new HD facility consisting of 6 to 9 stations is estimated
to be $2.5-3.5 million Canadian. Our scenario analysis
shows that implementing ICNHD to maximize use of
existing infrastructure may be advantages given the very
large capital costs of creating a new dialysis unit, despite
the greater incremental treatment costs of ICNHD relative
to CvHD. If the incremental treatment costs can be further
reduced, as by employing a self-care ICNHD program,
ICNHD becomes even more attractive. These estimates
should be approached with caution, as the true capital cost
of a new HD unit are not known with certainty, may vary
by setting and jurisdiction, and may be modified if the unit
is de novo or is utilizing currently unused space. Further,Figure 1 Scenario analyses of alternate staff-to-patient ratio with 50%
ICNHD, in-centre nocturnal hemodialysis; CvHD, conventional hemodialysisthe decision to create new units is also influenced by other
factors, including geographical considerations and antici-
pated future growth of the HD population,
ICNHD may be more attractive if other benefits are real-
ized. Although the clinical benefits of ICNHD have not
been rigorously evaluated, published literature suggests
clinical improvements are achieved. ICNHD improves
blood pressure and phosphate control, with concomitant
reductions in requirements of anti-hypertensives and phos-
phate binders compared with CvHD [6,13-17,20-26]. Re-
duced need for ESAs to achieve similar levels of
hemoglobin has also been found [13,15-17,21], although
not in RCTs; we have accounted for savings from reduced
ESA requirements for interest only as current evidence
does not support a reduction in use. Some studies have also
suggested reduced mortality and hospitalization rates for
ICNHD patients compared to CvHD patients [14,17,18].RN and 50% LPN. Costs are incremental compared with CvHD.
; RN, registered nurse; LPN, licensed practical nurse.
Table 3 Estimated incremental costs comparing construction of new dialysis unit vs. ICNHD (ICNHD – CvHD)
Size of new HD unit added
Capacity of added HD unit
25% 50% 75% 100%
4 stations (capital cost ~ $2,000,000)
1 year $1,942,775 $1,885,549 $1,828,324 $1,771,098
5 years $1,713,873 $1,427,745 $1,141,618 $855,490
10 years $1,427,745 $855,490 $283,236 (−$289,019)
6 stations (capital cost ~ $2,700,000)
1 year $2,614,162 $2,528,324 $2,442,485 $2,356,647
5 years $2,270,809 $1,841,618 $1,412,427 $983,236
10 years $1,841,618 $983,236 $124,853 (−$733,529)
9 stations (capital cost ~ $4,000,000)
1 year $3,866,474 $3,742,485 $3,608,959 $3,484,971
5 years $3,332,369 $2,712,427 $2,044,796 $1,424,853
10 years $2,664,739 $1,424,853 $89,592 (−$1,150,293)
Assumptions:
- all patients can be accommodated by ICNHD or would be treated with CvHD in a newly built in-centre dialysis unit of varying station capacity.
- annual operating cost per ICNHD patient $24586; annual operating cost per CvHD patient $15048 (incremental cost $ x annually).
- capital costs of establishing new HD units based on estimates from the Northern Alberta Renal Program.
- capacity refers to the use of stations within the unit, assuming 3 shifts per day, 6 days per week.
ICNHD: in-centre nocturnal hemodialysis; CvHD: conventional hemodialysis; HD: hemodialysis.
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not necessarily imply causation. To-date, there has been no
RCTs evaluating the benefits of ICNHD relative to other
HD modalities; most studies are either cohort studies or
before-after studies that are subject to the limitations with
respect to internal validity. As such, we have used potential
cost savings in scenario analyses, and have not conducted
a comprehensive economic evaluation that considers health
consequences, including cardiovascular events, and survival.
There have been few studies evaluating the quality of
life of ICNHD patients [13,22,25,27]. This precludes the
feasibility of conducting cost utility studies in this area
at present. However, there are potential productivity
gains afforded by ICNHD. ICNHD allows patients to
maintain full-time employment that would otherwise
not be possible with CvHD; it may also allow patients to
receive training for independent home HD in conjunction
with their HD treatments overnight, while maintaining
employment in the day. Future studies in ICNHD should
include quality of life measures and assessment of the ef-
fect on patients’ employment.
Our study has important strengths. Many economic eval-
uations have previously been performed on various forms of
intensive HD therapy, but to our knowledge, never with re-
spect to ICNHD. Using a micro-costing technique, we have
formally identified the incremental costs of ICNHD com-
pared with CvHD. However, we also acknowledge several
limitations with this study. First, cost comparisons between
ICNHD and CvHD were assumed to be equivalent with
regards to HD machine maintenance, patient-borne costs,
overhead, and physician billing. Potential cost differential inthese areas may be missed, but may not be important given
that differences in staffing costs between the two HD mo-
dalities contributed to a large proportion of the overall cost
differential. Second, in our scenario analysis, the cost of pa-
tient training for self-care ICNHD may be underestimated.
The relatively short training period was informed by the Al-
berta RCT, where a large proportion of patients who were
established on HNHD enrolled in this trial [4]. The average
duration of training may be higher in reality; in NARP,
new home HD patients typically require 6 weeks of train-
ing. However, the training cost accounted for a dedicated
RN performing patient training/teaching (in addition to
another nursing staff caring for the patient on dialysis),
thus potentially overestimating the staffing component of
training costs; our estimate of overall training costs may
be a reasonable approximation. Third, our estimates of the
relative reduction in medication requirements for ICNHD
patients were based on findings from a few cohort and
quasi-experimental studies [13-18]. The precise effect would
require more rigorous investigations, but we used conserva-
tive estimates in our analysis. Finally, the findings of this
cost analysis may not be generalizable to other health care
systems, including other parts of Canada. Differences in
physician billings, salary structures of RNs and LPNs, and
construction costs of new HD units may result in findings
different than those identified here.
Conclusions
In conclusion, we found that, compared to CvHD, provision
of ICNHD is more costly, largely driven by increased staff-
ing costs related to longer patient dialysis time. Alternate
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cost savings. The cost of treatment should be considered in
the context of impact on patient outcomes, staffing model,
and other factors, such as current available capacity for in-
centre HD.
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